Synovus Financial Corp increased its holdings in UnitedHealth Group Inc (NYSE:UNH) by 3.1% during the 4th quarter, Holdings Channel reports. The firm owned 72,800 shares of the healthcare conglomerate’s stock after buying an additional 2,191 shares during the period. Synovus Financial Corp’s holdings in UnitedHealth Group were worth $21,396,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also bought and sold shares of the stock. Cerebellum GP LLC bought a new position in UnitedHealth Group in the third quarter valued at approximately $80,000. SeaCrest Wealth Management LLC grew its stake in UnitedHealth Group by 3.4% in the third quarter. SeaCrest Wealth Management LLC now owns 2,981 shares of the healthcare conglomerate’s stock valued at $648,000 after purchasing an additional 97 shares in the last quarter. Massey Quick Simon & CO. LLC grew its stake in UnitedHealth Group by 212.5% in the third quarter. Massey Quick Simon & CO. LLC now owns 175 shares of the healthcare conglomerate’s stock valued at $38,000 after purchasing an additional 119 shares in the last quarter. Campbell & CO Investment Adviser LLC bought a new position in UnitedHealth Group in the third quarter valued at approximately $345,000. Finally, Ingalls & Snyder LLC grew its stake in UnitedHealth Group by 4.3% in the third quarter. Ingalls & Snyder LLC now owns 3,622 shares of the healthcare conglomerate’s stock valued at $787,000 after purchasing an additional 148 shares in the last quarter. 85.81% of the stock is currently owned by institutional investors.
UNH has been the subject of several research analyst reports. Piper Jaffray Companies lifted their target price on UnitedHealth Group from $312.00 to $325.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 4th. Cantor Fitzgerald lifted their target price on UnitedHealth Group from $315.00 to $330.00 and gave the stock an “overweight” rating in a research note on Thursday, January 16th. UBS Group lifted their target price on UnitedHealth Group from $279.00 to $304.00 and gave the stock a “neutral” rating in a research note on Thursday, January 16th. Morgan Stanley reiterated a “buy” rating and set a $312.00 target price (up from $294.00) on shares of UnitedHealth Group in a research note on Friday, November 22nd. Finally, Oppenheimer lifted their target price on UnitedHealth Group from $312.00 to $343.00 and gave the stock an “outperform” rating in a research note on Thursday, January 16th. Five analysts have rated the stock with a hold rating and nineteen have given a buy rating to the stock. The stock currently has an average rating of “Buy” and an average target price of $313.50.
UNH traded down $3.42 during trading on Friday, hitting $298.78. The stock had a trading volume of 2,485,506 shares, compared to its average volume of 4,099,015. The company has a 50 day moving average price of $291.30 and a 200-day moving average price of $260.18. The firm has a market cap of $271.94 billion, a price-to-earnings ratio of 20.85, a P/E/G ratio of 1.41 and a beta of 0.69. UnitedHealth Group Inc has a one year low of $208.07 and a one year high of $305.90. The company has a debt-to-equity ratio of 0.61, a current ratio of 0.69 and a quick ratio of 0.70.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Wednesday, January 15th. The healthcare conglomerate reported $3.90 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $3.77 by $0.13. The business had revenue of $60.90 billion during the quarter, compared to the consensus estimate of $61.17 billion. UnitedHealth Group had a return on equity of 25.55% and a net margin of 5.71%. The firm’s quarterly revenue was up 4.3% on a year-over-year basis. During the same period in the previous year, the company posted $3.28 EPS. As a group, sell-side analysts predict that UnitedHealth Group Inc will post 16.47 EPS for the current fiscal year.
In related news, EVP D Ellen Wilson sold 7,400 shares of the business’s stock in a transaction on Monday, November 18th. The stock was sold at an average price of $272.77, for a total value of $2,018,498.00. Also, Director Richard T. Burke sold 15,000 shares of the business’s stock in a transaction on Thursday, January 16th. The shares were sold at an average price of $299.45, for a total value of $4,491,750.00. Following the completion of the sale, the director now owns 158,598 shares of the company’s stock, valued at $47,492,171.10. The disclosure for this sale can be found here. Insiders own 0.82% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Recommended Story: What member countries make up the G-20?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.